---
title: "Wanchen Biotechnology submitted an application for the issuance and listing of H shares to the Hong Kong Stock Exchange and published the application materials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258598689.md"
description: "According to the Zhitong Finance APP, Wanchen Biotechnology announced that on September 23, 2025, the company submitted an application to the Hong Kong Stock Exchange Limited (hereinafter referred to as \"Hong Kong Stock Exchange\") for the issuance of overseas listed shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange. On the same day, the application materials for this issuance and listing were published on the Hong Kong Stock Exchange website"
datetime: "2025-09-24T00:03:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258598689.md)
  - [en](https://longbridge.com/en/news/258598689.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258598689.md)
generator: "portal-rs"
---

# Wanchen Biotechnology submitted an application for the issuance and listing of H shares to the Hong Kong Stock Exchange and published the application materials

According to the Zhitong Finance APP, Wanchen Biotechnology (300972.SZ) announced that on September 23, 2025, the company submitted an application to the Hong Kong Stock Exchange Limited (hereinafter referred to as "Hong Kong Stock Exchange") for the issuance of overseas listed shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange. The application materials for this issuance and listing were published on the Hong Kong Stock Exchange's website on the same day

### Related Stocks

- [300972.CN](https://longbridge.com/en/quote/300972.CN.md)

## Related News & Research

- [Cytospire Therapeutics names Sumeet Ambarkhane chief medical officer](https://longbridge.com/en/news/298433137.md)
- [National Franchise T.A.C.T. Celebrates Franchisee Feature in Esquire Magazine Highlighting Industry Excellence](https://longbridge.com/en/news/298459621.md)
- [CraniUS Therapeutics Receives FDA 510(k) Clearance for the CraniUS® Plate, a Patient-Specific Cranial Implant](https://longbridge.com/en/news/298452362.md)
- [NFL Biosciences flags CESTO2 post-hoc analysis on NFL-101 smoking-cessation biomarker at SFT congress](https://longbridge.com/en/news/298271560.md)
- [09:43 ETRiddle & Riddle Injury Lawyers Welcomes Arden Riddle to the Firm, Continuing a Multigenerational Legacy of Justice](https://longbridge.com/en/news/298330675.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**